$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2013 Q2 Form 10-Q Financial Statement

#000101489713000168 Filed on May 15, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q4
Revenue $451.00 $406.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $451.00 $406.00 $0.00
YoY Change
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $20.00K $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 4434.59% 0.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.25K $3.391K $0.00
YoY Change -66.09% -100.0%
Operating Profit -$14.80K -$2.985K $0.00
YoY Change -70.15% -100.0%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.327K -$323.00 $0.00
YoY Change
Pretax Income -$19.12K -$3.308K $0.00
YoY Change -66.92% -100.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$19.12K -$3.308K $0.00
YoY Change -66.92% -100.0%
Net Earnings / Revenue -4239.91% -814.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$4.444K $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $10.00K $0.00
YoY Change -100.0% 0.0% -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $10.00K $0.00
YoY Change -100.0% 0.0% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $10.00K $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $10.00K $0.00
YoY Change -100.0% 0.0% -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00 $0.00
YoY Change
Accrued Expenses $0.00 $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $30.00K $20.00K $20.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.00K $20.00K $20.00K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.00K $20.00K $20.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $30.00K $20.00K $20.00K
YoY Change 50.0% 0.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$30.00K -$20.00K -$17.24K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $10.00K $0.00
YoY Change -100.0% 0.0% -100.0%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q4
OPERATING ACTIVITIES
Net Income -$19.12K -$3.308K $0.00
YoY Change -66.92% -100.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00K $0.00 $0.00
YoY Change -100.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.000K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 10.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -20.00K 0.000 0.000
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 10.00K 10.00K 0.000
Net Change In Cash -10.00K 10.00K 0.000
YoY Change -200.0%
FREE CASH FLOW
Cash From Operating Activities -$20.00K $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
5073 USD

Files In Submission

Name View Source Status
0001014897-13-000168-index-headers.html Edgar Link pending
0001014897-13-000168-index.html Edgar Link pending
0001014897-13-000168.txt Edgar Link pending
0001014897-13-000168-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
ose10q1q13ex31.htm Edgar Link pending
ose10q1q13ex32.htm Edgar Link pending
ose10q1q13v1.htm Edgar Link pending
osok-20130331.xml Edgar Link completed
osok-20130331.xsd Edgar Link pending
osok-20130331_cal.xml Edgar Link unprocessable
osok-20130331_def.xml Edgar Link unprocessable
osok-20130331_lab.xml Edgar Link unprocessable
osok-20130331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending